Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA60 Degrees plans January 2027 results from its hospitalized babesiosis trial and will seek a pre-sNDA meeting with FDA.
- Dr. Sameena RahmanWhen Women Know Something Is Wrong, But Medicine Doesn't Listen: Dr. Sameena Rahman's New Book Examines the Bias, Culture and Silence Behind Women's Sexual HealthBrown Girls' Disease? A Guide to Sexual Health and Empowerment Through a South Asian Lens challenges patients and clinicians to rethink how women's pain, sexuality and health concerns are understood — What happens when a woman knows something is wrong,...
- Izotropic CorporationIzotropic Closes Non-Brokered Private PlacementIzotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces that further to its September 25th announcement it has completed a non-brokered private placement financing (the "Offering"), whereby the Company issued...
- Stryker announces leadership successionCompanies: Stryker CorporationStryker (NYSE:SYK), a global leader in medical technologies, today announced that as part of a planned succession process, Kevin Lobo will transition to the role of Executive Chair of the Board of Directors, effective January 1, 2027. Spencer Stiles, currently President and Chief Operating Officer of Stryker, will succeed Lobo as Chief Executive Officer and will also be appointed as a member of the company’s Board at that time.
- Invesport Partners acquires a stake in HumanFab to build a network of regional performance hubsFounded in 2010 in Aix-en-Provence by Dr Jean-Bernard Fabre, HumanFab has established itself as a singular player at the crossroads of sport, health and scientific research. Its concept brings together in a single location a multidisciplinary team of doctors, physiotherapists, strength and conditioning coaches, engineers and researchers, serving professional and amateur athletes alike. Drawing on […]
- Launch of Invesport Partners, an investment company dedicated to human performanceProven needs, missing infrastructure The analysis behind the creation of Invesport Partners starts with professional sport. Clubs invest heavily in their talent, yet very few have their own complete facility – assessment, physical preparation, recovery, medical and mental health support – together with the qualified staff to run it. The first consequence is player unavailability, […]
- /C O R R E C C I O N -- Piramal Pharma Solutions/Piramal Pharma Solutions ("PPS"), una organización líder mundial de desarrollo y fabricación por contrato (CDMO) y parte de Piramal Pharma Ltd....
- Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary SharesFORM 8.3
- /C O R R E C T I O N -- Piramal Pharma Solutions/Dans le communiqué de presse « Piramal Pharma Solutions inaugure un nouveau laboratoire de microbiologie dans son site de fabrication de produits injectables stériles de Lexington, dans le Kentucky », publié le 6 octobre 2026 par Piramal Pharma Solutions via PR Newswire, la société nous...
- Orion Pharma ja Qilu Pharma Europe sopimukseen pembrolitsumabi-biosimilaarituotteen oikeuksista EuroopassaORION OYJ LEHDISTÖTIEDOTE 6.10.2026 KLO 9.00
- Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European marketORION CORPORATION PRESS RELEASE 6 OCTOBER 2026 at 9.00 EEST
- Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmNew class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 11/1/2026